Registered entities
Pharmaxis Ltd.
Reg. No. 1301357United States
Innovation
27 patent families (12 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 978 times.
| Year | Filings |
|---|---|
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 4 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Social engagement
Social engagement: 4K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 5 | 45% |
| Other / undisclosed | 3 | 27% |
Recent activity
17 Jun 2026
Event
ECM Pharmacology Conference (ECM2026)
1 Jun 2026
Event
SNT-4728 webinar presentation
28 May 2026
Event
investor webinar on Phase 2 trial of SNT-4728